Amarogentin promotes osteoblast differentiation in oestrogen-deficiency-induced osteoporosis rats by modulating the Nrf-2/MAPK/ERK signalling pathway
Introduction The beneficial effect of amarogentin in the management of osteoporosis was determined using in vivo and in vitro methods. Material and methods Experimental osteoporosis was induced in rats via bilateral ovariectomy. Rats were then treated for 5 weeks with amarogentin (50 and 100 mg/kg,...
Main Authors: | Sirui Li, Xianlong Li, Feng He, Rui Jiao, Song Zhang, Zhihua Li |
---|---|
Format: | Article |
Language: | English |
Published: |
Termedia Publishing House
2019-11-01
|
Series: | Archives of Medical Science |
Subjects: | |
Online Access: | https://www.archivesofmedicalscience.com/Amarogentin-promotes-osteoblast-differentiation-in-oestrogen-deficiency-induced-osteoporosis,111137,0,2.html |
Similar Items
-
Anti‐inflammatory effects of amarogentin on 2,4‐dinitrochlorobenzene‐induced atopic dermatitis–like mice and in HaCat cells
by: Qian Zhang, et al.
Published: (2023-06-01) -
Effects of Amarogentin on Residual Liver Cancer Stem Cells After Insufficient Thermal Ablation and Related Mechanism
by: LIU Yan, et al.
Published: (2023-08-01) -
Of Oestrogens and Sperm: A Review of the Roles of Oestrogens and Oestrogen Receptors in Male Reproduction
by: Pavla Dostalova, et al.
Published: (2017-04-01) -
Thyroid-stimulating hormone decreases the risk of osteoporosis by regulating osteoblast proliferation and differentiation
by: Tuo Deng, et al.
Published: (2021-03-01) -
Modulation of immune functions by oestrogens. Part I
by: Jacek R. Wilczyński
Published: (2010-04-01)